Profiles

Keywords
Last Name
Institution

Connection

Gary Chmielewski to Dose-Response Relationship, Drug

This is a "connection" page, showing publications Gary Chmielewski has written about Dose-Response Relationship, Drug.

 
Connection Strength
 
 
 
0.114
 
  1. Theunissen PT, Beken S, Beyer B, Breslin WJ, Cappon GD, Chen CL, Chmielewski G, de Schaepdrijver L, Enright B, Foreman JE, Harrouk W, Hew KW, Hoberman AM, Y Hui J, Knudsen TB, Laffan SB, Makris SL, Martin M, McNerney ME, Siezen CL, Stanislaus DJ, Stewart J, Thompson KE, Tornesi B, Van der Laan JW, Weinbauer GF, Wood S, Piersma AH. Comparing rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on systemic dose and developmental effects. Crit Rev Toxicol. 2017 May; 47(5):402-414.
    View in: PubMed
    Score: 0.037
  2. Ripp SL, Aram JA, Bowman CJ, Chmielewski G, Conte U, Cross DM, Gao H, Lewis EM, Lin J, Liu P, Schlamm HT. Tissue distribution of anidulafungin in neonatal rats. Birth Defects Res B Dev Reprod Toxicol. 2012 Feb; 95(1):89-94.
    View in: PubMed
    Score: 0.027
  3. Bowman CJ, Chmielewski G, Lewis E, Ripp S, Sawaryn CM, Cross DM. Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges. Birth Defects Res B Dev Reprod Toxicol. 2011 Aug; 92(4):333-44.
    View in: PubMed
    Score: 0.026
  4. Bowman CJ, Chmielewski G, Oneda S, Finco D, Boucher MA, Todd M. Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys. Birth Defects Res B Dev Reprod Toxicol. 2010 Aug; 89(4):326-38.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.